Enhe Technology
恩和科技
elsewhere's corpus does not genuinely cover Enhe Technology as a subject. The bundle contains extensive material on **Enhe Biotechnology** (恩和生物 / Bota Bio), a synthetic biology company founded by Coral Chui, which raised over $100 million in Series B funding led by Sequoia China in July 2021 and began industrialization in 2023 . However, **Enhe Technology** (恩和科技) appears only as a name-drop in entity disambiguation with no substantive facts attached . No founding date, business description, funding history, or team details are provided.
AI-generated — may contain errors, please verify.
Coverage
Code Engraving | Enhe Launches BPL Protocol Language, Defining the "Industrial-Grade Compiler" for Bio-Manufacturing
For the first time, it established a formalized language system for biological experimental protocols, creating a standardized interface for Physical AI to enter the physical world.
Code Moment | Congratulations to METiS Pharmaceuticals on Its HKEX Listing, the World's First AI Drug Delivery Stock
Source Code Capital participated in METiS Pharmaceuticals' angel round in 2020 and continued to increase its stake in subsequent rounds.
Is the "ChatGPT Moment" for Bio-Manufacturing Here? | 5Y Talk
From the industry's ups and downs to the inflection point brought by AI, from a "lab crayfish" to the "ChatGPT moment" of bio-manufacturing.
In the Biological World, a Foothold for Physical AI
"In the seven years since Enhe was founded, how has an industrial technology company grown AI capabilities?"
Code Engraving | Enhe Technology Rebrands and Launches SAION AI: The World's First Physical AI Platform for Bio-manufacturing
A world-leading biomanufacturing company powered by Physical AI
